Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Roche announces US$ 50 bn investment in US to avoid tariffs; Regeneron signs US$ 3 bn onshoring deal with Fujifilm

After Eli Lilly, Johnson & Johnson and Novartis, Roche has announced plans to manufacture in the US to avoid tariffs. The Swiss...

Impressions : 816

Novartis to invest US$ 23 bn in US to avoid import tariffs; Pfizer halts development of GLP-1 weight-loss pill

After Eli Lilly and Johnson & Johnson, Novartis has become the latest big pharma to announce mega investments in the US. The ...

Impressions : 841

Pharma tariffs coming soon, warns Trump; GSK, Lilly ink billion-dollar deals for blood-brain barrier technology

In this week’s news, US President Donald Trump has said “major” pharmaceutical import tariffs are coming soon...

Impressions : 1013

CBER director forced out in FDA gutting; Sanofi, Alnylam's RNAi therapy Qfitlia wins US approval for hemophilia A, B

The pharma industry saw its most tumultuous week in the recent past with the US Food and Drug Administration (FDA) facing an un...

Impressions : 926

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Roche announces US$ 50 bn investment in US to avoid tariffs; Regeneron signs US$ 3 bn onshoring deal with Fujifilm

Novartis to invest US$ 23 bn in US to avoid import tariffs; Pfizer halts development of GLP-1 weight-loss pill

Pharma tariffs coming soon, warns Trump; GSK, Lilly ink billion-dollar deals for blood-brain barrier technology

CBER director forced out in FDA gutting; Sanofi, Alnylam's RNAi therapy Qfitlia wins US approval for hemophilia A, B

Kashiv Bio's Biologic FYLNETRA Receives Suppl Approval in US

Akeso's Biologic Penpulimab Receives Suppl Approval in US

BeiGene's Biologic Tevimbra Receives Suppl Approval in US

Centocor's Biologic Simponi Receives Suppl Approval in US

Janseen's Biologic Simponi Aria Receives Suppl Approval in US

Amgen's Biologic Bkemv Receives Suppl Approval in US

Aurobindo's Generics Esomeprazole Receives Approval in US

Micro Labs's Generics Latanoprost Receives Approval in US

Fresenius Kabi's Biologic Otulfi Receives Suppl Approval in US

BMS's Biologic Yervoy Receives Suppl Approval in US

Enforcement Report - Week of April 23, 2025

Amneal Issues a Nationwide Recall of Ropivacaine HCl

Enforcement Report - Week of April 16, 2025

PMS4PMS Receives FDA Warning Letter

Enforcement Report - Week of April 2, 2025

Health Canada Issues Recalls of Mint Pharma's Rosuvastatin

Enforcement Report - Week of March 26, 2025

Hangzhou Glamcos Biotech Receives FDA Warning Letter

Yangzhou Sion Receives FDA Warning Letter

Health Canada Issues Recalls of Sandoz's Fesoterodine

Merck starts $1 billion Biologics Center in Delaware, US

Pfizer Announces Another $1.7B in Cost Savings, R&D Revamp

Regeneron's first-quarter results miss on lower Eylea demand

FDA delays decision on Stealth' rare genetic disorder drug

Gilead to pay $202 M in US settlement over HIV drug kickbacks

AstraZeneca says potential US tariffs manageable

AstraZeneca's Truqap falls short in another phase 3 trial

Lilly pens $13M upfront oligonucleotide AI pact with Creyon Bio

IOL Chemicals Receives Approval CDE of NMPA, China for Ibuprofen

Guru Ramamurthy named CFO for Bayers Crop Science Division

Morepen Labs gets CDSCO clearance for Resmetirom studies

Abbott Highlights New AVEIR™ Data, Initiates Trial for Conduction

BMS Reports Mixed Earnings as Portfolio due to Generic Pressure

Novo protects US patients with legal wins against compounder

Lupin receives US FDA approval for generic Tolvaptan Tablets

Caplin Steriles approved by USFDA for Phytonadione Injectable

West Announces Q1 2025 Results, Raises EPS Guidance

Nordic Group's Subsidiary Launches Authorized Generic of Maxitrol

US generic drugs could get battered by tariffs, USP chief warns

J&J & Lilly Concealed Breast Cancer Risks in Antipsychotics Drug

Merck starts $1 billion Biologics Center in Delaware, US

Lilly pens $13M upfront oligonucleotide AI pact with Creyon Bio

Myosin Therapeutics gets $3M NIH grant for MT-110 trial

Takeda to launch dengue vaccine in India with Biological E

Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

After FDA rejection, Regeneron scores EU nod for Lynozyfic

Biohaven lands funding Oberland funding deal worth up to $600M

Merck KGaA in $3.9 B deal to buy US biotech firm SpringWorks

Dr Reddy's to introduce Sanofi's novel drug in India

Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial

Morepen Laboratories expands its domestic portfolio

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License

Divi's Lab inks supply pact with global pharmaceutical entity

Sustainability in Pharma Manufacturing: Path to Greener Future

Pharma companies may feel heat of US tariffs on China

Pharma APIs Storage: Ensuring Quality and Compliance

Novartis unveils $23B investment to beef up US manufacturing

USP, Ginkgo Partner With ARPA-H To Boost Essential Meds

APIs At the Core of Modern Medicine

2024 Universal Registration Document with Annual Financial Report

Sun Pharma to recall Levipil 500 immediately

Zydus gets 6 observations from USFDA for API unit

Justice Department unit for drug and food safety cases disbanded

Four states request USDA to ban soda, candy from food Assistance

Ozempic copies restricted after US judge denies injunction

Lupin recalls nearly 3,000 bottles of OCD drug in US

Bausch + Lomb to Return enVista Intraocular Lenses After Recall

Delhi HC orders cough syrup makers to warn against child use

ICMR for selective ban on popular painkiller

Amneal recalls 2 lots of hospital med over contamination fears

Metrion Launches Nav1.9 HTS Assay for Pain Drug Research

Wayne Wilson Wins Silver Stevie® Award in 2025 ABA

Eurosets Unveils Breathe, Xtreme Rescue at EuroELSO 2025